XEBRA BRANDS LTD - XBRAF STOCK NEWS

Xebra Brands Ltd. (CSE: XBRA, OTCQB: XBRAF) announced plans to launch its cannabis beverage, Vicious Citrus Lemonade, in Canada, targeting Alberta, British Columbia, and Ontario. This beverage contains 10mg of THC and 2mg of CBN per serving, offering a unique consumption experience due to the synergistic effects of cannabinoids. Vicious Citrus Lemonade is notably among the few beverages with CBN in Canada and utilizes tested emulsion IP. Production is set to start in spring 2022, aiming for a summer launch, with positive feedback from provinces and dispensaries noted.

Xebra Brands Ltd. (CSE: XBRA) (OTCQB: XBRAF) has achieved eligibility for DTC services, enhancing the liquidity of its shares for U.S. investors. This development simplifies the trading process and reduces costs for investors and brokers, allowing wider access to Xebra's shares. President Rodrigo Gallardo noted this as a significant milestone in increasing corporate visibility and facilitating U.S. investment in the company. DTC serves as a clearinghouse for electronically traded securities in the U.S., streamlining settlements.

Xebra Brands Ltd. (CSE: XBRA, OTCQB: XBRAF) announces a non-brokered private placement aiming for gross proceeds of up to CAD$1,200,000. The offering consists of up to 10,000,000 units priced at CAD$0.12 per unit, each unit containing one common share and a half warrant. Each full warrant can be exercised to buy a common share at CAD$0.25 for 12 months. The proceeds will be allocated for general working capital. The placement is subject to Canadian Securities Exchange approval.

Xebra Brands Ltd. (CSE: XBRA) has announced the granting of trademarks for its cannabis-infused beverage brands in various Latin American countries, including Argentina, Brazil, and Colombia. The trademarks include names such as MADCAP for soft drinks and VICIOUS CITRUS for lemonades, along with catchy slogans. This move supports Xebra's strategy to secure global trademark protection as cannabis legalization expands. The company is also focused on launching its products in Canada and completing agronomical evaluations in Colombia for future cannabis activities.

Xebra Brands Ltd. (CSE: XBRA, OTCQB: XBRAF) has completed all conditions to license its Solutech™ technology from New Age Nanotech. This patent-pending cannabinoid emulsion technology converts cannabis extracts into shelf-stable, water-soluble forms for beverages and edibles. Unique for its completion of a Phase-I human clinical trial, Solutech™ is poised for commercialization, starting with the launch of Vicious Citrus THC Lemonade in Canada in Spring 2022. Xebra holds exclusive rights for production in Mexico and Colombia and non-exclusive rights in Europe and the Americas.

Xebra Brands Ltd. (OTCQB: XBRAF) announced the granting of trademarks in the European Union for its THC and CBD-infused beverage brands, covering 28 countries and 10 territories. The trademarks include MADCAP soft drinks, HOLAHI iced teas, HIGHJACK energy drinks, VICIOUS CITRUS lemonades, and HIGHCASTLE waters, along with the CONQUER CBD sports drink. Xebra also holds a cannabis injunction from the Mexican Supreme Court, positioning it strongly in Mexico's CBD and CBG sectors. The company has plans to launch Vicious Citrus lemonade in Canada in spring 2022 and is evaluating cannabis seed varieties in Colombia.

Xebra Brands Ltd. (CSE: XBRA) (OTCQB: XBRAF) has completed its 100% acquisition of Desart MX, issuing 48 million shares to Mexican vendors, held in escrow for 38 months. Desart secured an irrevocable injunction from the Mexican Supreme Court, giving it a first-mover advantage in the CBD and CBG market, allowing for low-THC cannabis cultivation. Xebra plans to secure land for cultivation and explore joint ventures with US and Canadian companies, aiming to leverage Mexico's position within the North American market.

Xebra Brands Ltd. (CSE: XBRA, OTC: XBRAF) has upgraded its listing to trade on the OTCQB Venture Markets as of January 10, 2022. This transition aims to enhance liquidity and provide a seamless trading experience for U.S. investors. The upgrade mandates greater transparency and reporting standards, including exemptions from U.S. state securities laws. Additionally, Xebra has submitted an application for DTC eligibility to FINRA.

Xebra Brands Ltd. (CSE: XBRA, OTC: XBRAF) has officially begun cannabis cultivation in the Netherlands, focusing on THC varietals. Selected as one of only five companies by the Dutch government for a medicinal cannabis cultivation trial, Xebra aims to secure one of two licenses that could yield revenues of up to US$79 million (€70.5 million) over a six-year contract. Cultivation occurs in an indoor facility with high-quality genetic varieties and a growth cycle of 12-16 weeks, led by industry expert Harry von Duijne.